Skip to main content
    C

    CVRx Inc (CVRX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.39
    +0.05 (+3.73%)

    Market Cap: $39.43M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    55%(12/22)
    Avg Surprise
    -8.97%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.50
    Range$-0.53 - $-0.47
    5 analysts
    EPS Revisions
    3
    0
    7d
    3
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.48-5.2%
    60d ago$-0.48-3.8%
    30d ago$-0.48-3.8%
    7d ago$-0.48-3.8%
    Current$-0.50
    Revenue Consensus
    $14M
    Range$14M - $14M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.49
    Range$-0.53 - $-0.42
    5 analysts
    Revenue Consensus
    $15M
    Range$14M - $15M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.49---
    Sep 26EST
    		-$-0.50---
    Jun 26
    Reported Aug 6
    		$-0.53$-0.52-1.92%Miss+7.0%
    Mar 26
    Reported May 11
    		$-0.50$-0.50+0.00%Beat+5.7%
    Dec 25
    Reported Feb 12
    		$-0.46$-0.44-4.55%Miss-7.0%
    Sep 25
    Reported Nov 5
    		$-0.49$-0.50+2.00%Beat+14.0%
    Jun 25
    Reported Aug 4
    		$-0.57$-0.52-9.62%Miss+12.3%
    Mar 25
    Reported May 8
    		$-0.53$-0.57+7.02%Beat+49.0%
    Dec 24
    Reported Feb 4
    		$-0.43$-0.38-13.16%Miss+2.3%
    Sep 24
    Reported Oct 29
    		$-0.57$-0.47-21.28%Miss-32.6%
    Jun 24
    Reported Jul 29
    		$-0.65$-0.55-18.18%Miss-16.1%
    Mar 24
    Reported Apr 30
    		$-1.04$-0.54-92.59%Miss-89.1%
    Dec 23
    Reported Jan 25
    		$-0.44$-0.55+20.00%Beat+13.7%
    Sep 23
    Reported Oct 26
    		$-0.43$-0.58+25.86%Beat+10.4%
    Jun 23
    Reported Jul 25
    		$-0.56$-0.58+3.45%Beat-3.7%
    Mar 23
    Reported Apr 27
    		$-0.55$-0.57+3.51%Beat-12.2%
    Dec 22
    Reported Jan 26
    		$-0.51$-0.56+8.93%Beat+1.9%
    Sep 22
    Reported Nov 1
    		$-0.48$-0.56+14.29%Beat-60.0%
    Jun 22
    Reported Jul 28
    		$-0.54$-0.53-1.89%Miss+98.9%
    Mar 22
    Reported Apr 25
    		$-0.49$-0.49+0.00%Beat+30.0%
    Dec 21
    Reported Feb 15
    		$-0.52$-0.44-18.18%Miss+14.0%
    Sep 21
    Reported Nov 4
    		$-0.30$-0.40+25.00%Beat-45.8%
    Jun 21
    Reported Aug 4
    		$-48.48$-21.45-126.01%Miss-
    Mar 21
    Reported Jun 2
    		$-0.70$-0.70+0.00%Beat-
    Dec 20
    Reported Mar 31
    		$-0.60$0.00N/AMiss-
    Dec 19
    Reported Mar 30
    		$-0.21$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.70EV/EBITDAN/A
    Price/FCF-0.90xFCF Yield-111.39%
    Profitability
    Profit Margin-84.90%Operating Margin-82.90%
    ROE-133.50%ROIC-58.51%
    Financial Health
    Debt/Equity2.94xInterest Coverage-7.62x
    Current Ratio8.04xQuick Ratio6.87x
    Trading Statistics
    Beta0.77Avg Volume764.54K
    52-Week High$11.3052-Week Low$1.35

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.52
    SMA 20$2.03
    SMA 50$2.62
    SMA 200$5.61
    EMA 10$1.59
    EMA 20$1.93
    EMA 50$2.73
    EMA 200$5.03

    MACD

    Line: -0.44Signal: -0.42Hist: -0.02

    ADX

    ADX: 39.1+DI: 11.5-DI: 37.4

    Aroon & PSAR

    Aroon Up16.0
    Aroon Down96.0
    PSAR$2.01

    Bollinger Bands

    Upper Band$3.29
    Lower Band$0.77
    %B Position12412%(Upper)
    Band Width0.25

    RSI (14-Day)

    Oversold
    24.7

    Momentum Oscillators

    Stoch %K4.0
    Stoch %D2.7
    Williams %R-92.7
    ROC (10d)-9.2%
    Momentum-0.14
    CCI (20d)-78.0
    MFI (14d)17.2

    Volatility Measures

    ATR (14d)$0.21(15.0%)
    StdDev (20d)0.63
    Hist Vol136.2%(High)

    Volume Flow

    VWAP$1.39
    OBV-3.5M
    AD Line-10.4M
    CMF (20d)-0.411

    Volume Metrics

    Avg Vol (20d)805.1K
    Vol Ratio0.4x(Low)
    VWMA (20d)$1.91

    Pivot Points

    R3$1.52
    R2$1.46
    R1$1.40
    Pivot Point$1.34
    S1$1.28
    S2$1.22
    S3$1.16

    Advanced Oscillators

    TSI-48.94
    Ultimate Osc33.3
    KST-441.17

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$15.71M$14.77M$16.02M$14.69M$13.59M$12.35M$15.34M$13.37M$11.81M$10.77M$11.30M$10.51M
    Cost of Revenue$1.98M$1.89M$2.20M$1.94M$2.14M$2.04M$2.57M$2.25M$1.90M$1.61M$1.72M$1.69M
    Gross Profit$13.72M$12.88M$13.82M$12.75M$11.45M$10.31M$12.77M$11.13M$9.91M$9.15M$9.59M$8.82M
    Operating Expenses$26.75M$25.04M$25.01M$25.02M$25.83M$23.75M$23.05M$24.14M$23.88M$31.39M$19.25M$18.35M
    R&D$3.13M$3.08M$3.00M$3.15M$2.47M$2.52M$2.81M$2.50M$2.77M$3.06M$2.24M$2.70M
    SG&A$23.62M$21.96M$22.01M$21.88M$23.36M$21.23M$20.24M$21.63M$21.11M$28.33M$17.00M$15.65M
    Operating Income$-13,023,000$-12,161,000$-11,184,000$-12,268,000$-14,376,000$-13,437,000$-10,274,000$-13,011,000$-13,973,000$-22,232,000$-9,661,000$-9,528,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$1.58M$1.55M$1.42M$1.48M$1.47M$1.46M$1.52M$958,000$959,000$960,000$579,000$499,000
    Income Before Tax$-14,041,000$-13,119,000$-11,941,000$-12,873,000$-14,739,000$-13,771,000$-10,722,000$-13,052,000$-13,988,000$-22,148,000$-9,124,000$-8,971,000
    Income Tax Expense$3,000$1,000$-7,000$-3,000$-3,000$-5,000$-71,000$47,000$41,000$38,000$39,000$40,000
    Net Income$-14,044,000$-13,120,000$-11,934,000$-12,870,000$-14,736,000$-13,766,000$-10,651,000$-13,099,000$-14,029,000$-22,186,000$-9,163,000$-9,011,000
    EBITDA$-12,170,000$-11,280,000$-10,278,000$-11,138,000$-13,013,000$-12,071,000$-8,963,000$-11,880,000$-12,839,000$-21,009,000$-8,376,000$-8,294,000
    EBIT$-12,463,000$-11,568,000$-10,524,000$-11,393,000$-13,266,000$-12,314,000$-9,202,000$-12,094,000$-13,029,000$-21,188,000$-8,545,000$-8,472,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CVRX

    Government Contracts

    Gov Obligations (TTM)
    $0
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    0
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    CVRx lowers 2026 outlook, Canaccord keeps Buy for CVRx stock

    CVRx has lowered its fiscal 2026 revenue outlook to $58.00-$60.00 million, primarily due to salesforce productivity issues and a mixed reimbursement picture...

    ad-hoc-news.de•10/13/26•Neutral

    CVRx Q2FY26 Results: Revenue up 16%, full-year guidance lowered

    CVRx Inc. reported a 16% year-over-year revenue increase to $15.7 million for Q2FY26 but lowered its full-year guidance to $58-$60 million due to salesforce productivity issues from high turnover. Despite narrowing net...

    scanx.trade•10/12/26•Somewhat-Bearish

    CVRx Reports Q2 2026 Results: Full Earnings Call Transcript

    CVRx reported Q2 2026 revenue of $15.7 million, a 16% year-over-year increase, but lowered its full-year guidance due to salesforce productivity issues stemming from high turnover and new hires...

    Benzinga•10/12/26•Somewhat-Bearish

    CVRx stock gained 3.85 percent ahead of Barostim data

    CVRx stock saw a 3.85% gain, closing at USD 1.62, in anticipation of Barostim data presentations at the Heart Failure Society of America meeting starting October 9...

    AD HOC NEWS•10/7/26•Somewhat-Bullish

    Canaccord keeps Buy for CVRx stock as CVRx appoints John Landry CFO

    Canaccord Genuity has maintained its Buy rating and a $5.00 price target for CVRx stock following the appointment of John Landry as the new Chief Financial Officer. Landry, previously CFO of Nyxoah and Vapotherm...

    AD HOC NEWS•10/6/26•Neutral

    CVRX Valuation and Fair Value

    P/E
    -0.7x
    P/FCF
    -0.9x
    P/B
    1.8x
    See GNG's fair value

    CVRX Profitability: Margins, ROIC and FCF

    Gross margin
    86.9%
    Operating margin
    -82.9%
    Net margin
    -84.9%
    ROIC
    -58.5%
    ROE
    -133.5%
    FCF margin
    -67.1%
    FCF yield
    -111.4%

    CVRX Competitors

    CompanyTicker
    Scynexis IncSCYX
    FibroGen IncFGEN
    Grace Therapeutics, Inc.GRCE
    Cosmos Health Inc.COSM
    Nano X Imaging LtdNNOX
    Nephros IncNEPH
    Instil Bio Inc.TIL
    Veru IncVERU

    Sector: Healthcare

    CVRX Analyst Ratings

    Consensus
    Hold
    Analysts
    7
    Strong Buy
    0
    Buy
    3
    Hold
    3
    Sell
    0
    Strong Sell
    1

    CVRX Bull Case vs Bear Case

    Bull case

    • CVRX grew quarterly revenue 15.6% year over year.

    Bear case

    • CVRX has a -84.9% net profit margin.
    • CVRX beat EPS estimates in 25.0% of its last 8 reported quarters.
    • CVRX has a debt-to-equity ratio of 2.9x.

    CVRX Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -5.2%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.50
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    3 up, 2 down

    Frequently Asked Questions About CVRX

    Does CVRX pay dividends?

    CVRx Inc (CVRX) does not currently pay a regular dividend.

    What is CVRX's market cap?

    CVRx Inc (CVRX) has a market capitalization of $39.43M with a current stock price of $1.39.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In